Allogene Therapeutics Inc (NASDAQ:ALLO) Stock Price Settled at $3.55: What’s Resulting?
JMP Securities raised the price target for the Allogene Therapeutics Inc (NASDAQ:ALLO) stock from “a Mkt outperform” to “a Mkt perform”. The rating was released on January 05, 2024, according to finviz. The research report from Citigroup has initiated the stock to Buy, with a price target set at $7. In their research brief published […]
Faced with a depressed economy, Allogene Therapeutics Inc (ALLO) Stock offers an opportunity
JMP Securities raised the price target for the Allogene Therapeutics Inc (NASDAQ:ALLO) stock from “a Mkt outperform” to “a Mkt perform”. The rating was released on January 05, 2024, according to finviz. The research report from Citigroup has initiated the stock to Buy, with a price target set at $7. In their research brief published […]
Allogene Therapeutics Inc (ALLO) Stock offers help to cash-strapped investors
JMP Securities raised the price target for the Allogene Therapeutics Inc (NASDAQ:ALLO) stock from “a Mkt outperform” to “a Mkt perform”. The rating was released on January 05, 2024, according to finviz. The research report from Citigroup has initiated the stock to Buy, with a price target set at $7. In their research brief published […]
What does the future hold for Allogene Therapeutics Inc (ALLO) Stock?
JMP Securities raised the price target for the Allogene Therapeutics Inc (NASDAQ:ALLO) stock from “a Mkt outperform” to “a Mkt perform”. The rating was released on January 05, 2024, according to finviz. The research report from Citigroup has initiated the stock to Buy, with a price target set at $7. In their research brief published […]
Getting Ready for the Bounce: Allogene Therapeutics Inc (ALLO) Stock
JMP Securities raised the price target for the Allogene Therapeutics Inc (NASDAQ:ALLO) stock from “a Mkt outperform” to “a Mkt perform”. The rating was released on January 05, 2024, according to finviz. The research report from Citigroup has initiated the stock to Buy, with a price target set at $7. In their research brief published […]
A leader in the success game: Allogene Therapeutics Inc (ALLO) Stock
JMP Securities raised the price target for the Allogene Therapeutics Inc (NASDAQ:ALLO) stock from “a Mkt outperform” to “a Mkt perform”. The rating was released on January 05, 2024, according to finviz. The research report from Citigroup has initiated the stock to Buy, with a price target set at $7. In their research brief published […]
The high-quality value of Allogene Therapeutics Inc (ALLO) Stock is hidden beneath the surface
JMP Securities raised the price target for the Allogene Therapeutics Inc (NASDAQ:ALLO) stock from “a Mkt outperform” to “a Mkt perform”. The rating was released on January 05, 2024, according to finviz. The research report from Citigroup has initiated the stock to Buy, with a price target set at $7. In their research brief published […]
